BAXTER INTERNATIONAL INC acquires Gambro AB
Snapshot
BAXTER INTERNATIONAL INC acquired Gambro AB for SEK 26.5 billion total consideration (approximately $4.0 billion), including payoff of existing Gambro indebtedness in September 2013. The transaction was structured as all cash. Gambro AB is a Lund, Sweden (global operations)-based Renal / dialysis business.
- Acquirer
- BAXTER INTERNATIONAL INC
- Target
- Gambro AB
- Value
- SEK 26.5 billion total consideration (approximately $4.0 billion), including payoff of existing Gambro indebtedness
- Date
- September 2013
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
BAXTER INTERNATIONAL INC acquired Gambro AB for SEK 26.5 billion total consideration (approximately $4.0 billion), including payoff of existing Gambro indebtedness, a transaction completed in September 2013, structured as all cash.
Gambro AB operates in Renal / dialysis, is based in Lund, Sweden (global operations). Gambro is a privately held global medical technology company based in Lund, Sweden, focused on developing, manufacturing and supplying dialysis products and therapies used in hemodialysis and continuous renal replacement therapy for patients with acute or chronic kidney disease.
The acquisition gives Baxter a comprehensive dialysis product portfolio, complements Baxter's global home dialysis offerings, and positions the company to better meet the evolving needs of the large and growing dialysis market by extending its portfolio in the hemodialysis segment.
Created a comprehensive, complementary global dialysis portfolio across home and in-center therapies in a large and growing market with more than two million patients globally on dialysis. Baxter expected the transaction to support accelerated sales and earnings growth over its long-range financial plan. Integrated into Baxter's Renal business
No advisory firms have been disclosed for this transaction.